Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe 7.5mg Mounjaro pen delivers its dose in 40 clicks of the KwikPen dial. Each click equals 0.05mg of tirzepatide, so 40 clicks brings you to the full 7.5mg weekly dose — confirmed across Eli Lilly's prescribing information and the Mounjaro SmPC on the eMC. That click-count only applies to the 7.5mg pen; the number changes on every other strength. If you are currently on this dose and have questions about your next steps, those decisions belong with your prescriber, not a click-count article — but the mechanics are straightforward and worth understanding.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The KwikPen is designed so that every single click of the dial moves 0.05mg of tirzepatide into position. That increment is consistent across all Mounjaro pen strengths, it's a fixed mechanical property of the device, not something that varies pen to pen. To reach 7.5mg you therefore need 0.05mg × 40 = 7.5mg. The pen holds enough solution for four of those weekly doses, so one 7.5mg pen lasts a full four weeks.
Understanding the arithmetic matters most when you are checking that you have dialled correctly before an injection. The display window on the pen shows the dose number; the click count is an audio-tactile cross-check, not the primary readout. If you cannot hear or feel clicks clearly, the window figure is what counts. For anything beyond that (how to hold the pen, injection technique, what to do if a dose is missed) the Patient Information Leaflet that comes in the box is the right reference, and your prescriber or pharmacist can clarify further.
One practical note: the pen should arrive refrigerated, and our full Mounjaro guide covers storage requirements in detail. Keep it in the fridge between uses and allow it to reach room temperature before injecting, in line with the SmPC guidance.
No, and this is where confusion most commonly arises. If a pharmacist or clinician has ever supplied you with a higher-strength pen and asked you to dial back to a lower dose, the click count changes entirely. The 7.5mg KwikPen is pre-set: it can only deliver 7.5mg per injection. But if you were using, for example, a 10mg or 12.5mg pen and needed to extract a 7.5mg dose, the calculation would need to be worked through from that pen's starting parameters.
That scenario is not standard practice. Mounjaro pens are dispensed at the exact strength prescribed, so in normal use you dial to the full dose on the pen in your hand. Pages covering related click questions (including how many clicks is 5mg on a 7.5mg pen and dialling 2.5mg from the 7.5mg pen) go into those specific scenarios if your situation is more unusual. The broader context for how Mounjaro clicks map to doses across strengths is also covered separately.
The short answer: if your prescription says 7.5mg and you have a 7.5mg pen, 40 clicks is correct.
Tirzepatide treatment starts at 2.5mg, a tolerability dose whose job is to let your system adjust, not to produce the bulk of any weight change. From there the prescriber typically increases by 2.5mg every four weeks, subject to how well the previous dose was tolerated. That puts 7.5mg as the third rung: after 2.5mg and 5mg, and before the maintenance range of 10, 12.5 and 15mg.
The NHS tirzepatide medicines page describes this schedule clearly. SURMOUNT-1 trial results (involving 2,539 adults over 72 weeks) found the greatest average weight reductions at the highest doses, with 15mg producing roughly 20–21% average body-weight loss. That evidence is why the titration schedule exists: moving through 7.5mg is part of reaching the doses where the strongest clinical effects were seen in trials. More on what the 7.5mg dose involves is covered on its own page.
Whether you stay at 7.5mg or continue upward depends on tolerability and clinical judgement, not on a fixed rule. A question our prescribers hear regularly is whether a patient must titrate to 15mg, they do not. The right maintenance dose is the highest one a person tolerates well, which can be any strength in the licensed range.
The 5mg Mounjaro pen delivers its full dose in 20 clicks, half the number of the 7.5mg pen, because the dose is lower while the per-click increment remains 0.05mg. Knowing this distinction matters if you have ever had both strengths in the house at the same time, or if a prescription change means the box on your fridge door has changed colour and strength.
Mounjaro pens are colour-coded by strength, which helps with quick identification. Even so, confirming the strength printed on the label before dialling is a good habit. If you have ever seen a reference to 40 clicks on a 5mg pen, that describes a different scenario entirely, double the normal 5mg dose, which is not a standard prescription and would require specific clinical instruction.
For context on what treatment costs at different stages, the Mounjaro price guide explains how private pricing works across strengths. These are prescription-only medicines; obtaining them requires a clinical assessment by a registered prescriber, and a legitimate supply always comes through a pharmacy you can verify on the GPhC pharmacy register. If you are considering starting treatment or want a prescriber to review your current dose, a free consultation with our clinical team is the right next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.